Generation Bio Co
NASDAQ:GBIO

Watchlist Manager
Generation Bio Co Logo
Generation Bio Co
NASDAQ:GBIO
Watchlist
Price: 1.4 USD 2.19% Market Closed
Market Cap: 93.5m USD
Have any thoughts about
Generation Bio Co?
Write Note

EV/EBIT
Enterprise Value to EBIT

0.9
Current
0.1
Median
4.1
Industry
Higher than median
Lower than industry value

Enterprise Value to EBIT (EV/EBIT) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s earnings before interest and taxes (EBIT). Considered one of the most frequently used multiples for comparisons among companies, the EV/EBIT multiple relies on operating income as the core driver of valuation.

EV/EBIT
0.9
=
Enterprise Value
-91.3m USD
/
EBIT
-97.7m USD
All Countries
Close
EBIT Growth
US
Generation Bio Co
NASDAQ:GBIO
Average EV/EBIT: 19.4
0.9
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -216 722.5 N/A
US
Abbvie Inc
NYSE:ABBV
24.1
88%
US
Amgen Inc
NASDAQ:AMGN
31.3
93%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
26
44%
US
Gilead Sciences Inc
NASDAQ:GILD
10
29%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -501.6 N/A
AU
CSL Ltd
ASX:CSL
25.6
55%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18
54%
US
S
Seagen Inc
F:SGT
Negative Multiple: -53.1 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -75.8 N/A

EV/EBIT Forward Multiples

Forward EV/EBIT multiple is a version of the EV/EBIT ratio that uses forecasted EBIT for the EV/EBIT calculation. 1-Year, 2-Years, and 3-Years forwards use EBIT forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBIT
0.6
2-Years Forward
EV/EBIT
1.1
3-Years Forward
EV/EBIT
1.1

See Also

Discover More